Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
ALLO holding history
Allogene Therapeutics, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −8,011−100.0% | Sold out | Holders |
| Q3 2024 | 8,011 | $21.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 8,011 | $16.7K | <0.1% | +8,011 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −5,076−100.0% | Sold out | Holders |
| Q1 2022 | 5,076 | $46.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 5,076 | $61.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 5,076 | $130.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 5,076 | $132.0K | <0.1% | – | No prior filing | Holders |